|
1
|
Berns KI and Parrish CR:
ParvoviridaeFields Virology. Knipe DM, Howley PM, Cohen JI, Griffin
DE, Lamb RA, Martin MA, Racaniello VR and Roizman B: 6th.
Lippincott Williams & Wilkins; Philadelphia, PA: pp. 1768–1791.
2013
|
|
2
|
Qiu J, Söderlund-Venermo M and Young NS:
Human parvoviruses. Clin Microbiol Rev. 30:43–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cossart YE, Field AM, Cant B and Widdows
D: Parvovirus-like particles in human sera. Lancet. 1:72–73. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown KE and Young NS: Parvovirus B19 in
human disease. Annu Rev Med. 48:59–67. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heegaard ED and Brown KE: Human parvovirus
B19. Clin Microbiol Rev. 15:485–505. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Young NS and Brown KE: Parvovirus B19. N
Engl J Med. 350:586–597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Page C, François C, Goëb V and Duverlie G:
Human parvovirus B19 and autoimmune diseases. Review of the
literature and pathophysiological hypotheses. J Clin Virol.
72:69–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allander T, Tammi MT, Eriksson M, Bjerkner
A, Tiveljung-Lindell A and Andersson B: Cloning of a human
parvovirus by molecular screening of respiratory tract samples.
Proc Natl Acad Sci USA. 102:pp. 12891–12896. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jartti T, Hedman K, Jartti L, Ruuskanen O,
Allander T and Söderlund-Venermo M: Human bocavirus-the first 5
years. Rev Med Virol. 22:46–64. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naides SJ and Weiner CP: Antenatal
diagnosis and palliative treatment of non-immune hydrops fetalis
secondary to fetal parvovirus B19 infection. Prenat Diagn.
9:105–114. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feldman AM and McNamara D: Myocarditis. N
Engl J Med. 343:1388–1398. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murry CE, Jerome KR and Reichenbach DD:
Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol.
32:342–345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamparter S, Schoppet M, Pankuweit S and
Maisch B: Acute parvovirus B19 infection associated with
myocarditis in an immunocompetent adult. Hum Pathol. 34:725–728.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kühl U, Pauschinger M, Bock T, Klingel K,
Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP
and Kandolf R: Parvovirus B19 infection mimicking acute myocardial
infarction. Circulation. 108:945–950. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pankuweit S, Moll R, Baandrup U, Portig I,
Hufnagel G and Maisch B: Prevalence of the parvovirus B19 genome in
endomyocardial biopsy specimens. Hum Pathol. 34:497–503. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pankuweit S, Lamparter S, Schoppet M and
Maisch B: Parvovirus B19 genome in endomyocardial biopsy specimen.
Circulation. 109:e1792004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dorsch S, Liebisch G, Kaufmann B, von
Landenberg P, Hoffmann JH, Drobnik W and Modrow S: The VP1 unique
region of parvovirus B19 and its constituent phospholipase A2-like
activity. J Virol. 76:2014–2018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Filippone C, Zhi N, Wong S, Lu J, Kajigaya
S, Gallinella G, Kakkola L, Söderlund-Venermo M, Young NS and Brown
KE: VP1u phospholipase activity is critical for infectivity of
full-length parvovirus B19 genomic clones. Virology. 374:444–452.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leisi R, Ruprecht N, Kempf C and Ros C:
Parvovirus B19 uptake is a highly selective process controlled by
VP1u, a novel determinant of viral tropism. J Virol.
87:13161–13167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu TC, Tsai CC, Chiu CC, Hsu JD and Tzang
BS: Exacerbating effects of human parvovirus B19 NS1 on liver
fibrosis in NZB/W F1 mice. PLoS One. 8:e683932013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai CC, Chiu CC, Hsu JD, Hsu HS, Tzang BS
and Hsu TC: Human parvovirus B19 NS1 protein aggravates liver
injury in NZB/W F1 mice. PLoS One. 8:e597242013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nie X, Zhang G, Xu D, Sun X, Li Z, Li X,
Zhang X, He F and Li Y: The VP1-unique region of parvovirus B19
induces myocardial injury in mice. Scand J Infect Dis. 42:121–128.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC
and Hsu TC: Increased cardiac injury in NZB/W F1 mice received
antibody against human parvovirus B19 VP1 unique region protein.
Mol Immunol. 48:1518–1524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bogomolovas J, Šimoliūnas E, Rinkūnaitė I,
Smalinskaitė L, Podkopajev A, Bironaitė D, Weis CA, Marx A,
Bukelskienė V, Gretz N, et al: A novel murine model of parvovirus
associated dilated cardiomyopathy induced by immunization with
VP1-unique region of parvovirus B19. Biomed Res Int.
2016:16271842016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qu XW, Liu WP, Qi ZY, Duan ZJ, Zheng LS,
Kuang ZZ, Zhang WJ and Hou YD: Phospholipase A2-like activity of
human bocavirus VP1 unique region. Biochem Biophys Res Commun.
365:158–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS
and Hsu TC: The association of VP1 unique region protein in acute
parvovirus B19 infection and anti-phospholipid antibody production.
Clin Chim Acta. 378:59–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiu CC, Shi YF, Yang JJ, Hsiao YC, Tzang
BS and Hsu TC: Effects of human Parvovirus B19 and Bocavirus VP1
unique region on tight junction of human airway epithelial A549
cells. PLoS One. 9:e1079702014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zádori Z, Szelei J, Lacoste MC, Li Y,
Gariépy S, Raymond P, Allaire M, Nabi IR and Tijssen P: A viral
phospholipase A2 is required for parvovirus infectivity. Dev Cell.
1:291–302. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bonnerot C, Rocancourt D, Briand P,
Grimber G and Nicolas JF: A beta-galactosidase hybrid protein
targeted to nuclei as a marker for developmental studies. Proc Natl
Acad Sci USA. 84:pp. 6795–6799. 1987; View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Valaperti A: Drugs targeting the canonical
NF-κB pathway to treat viral and autoimmune myocarditis. Curr Pharm
Des. 22:440–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gullestad L, Ueland T, Vinge LE, Finsen A,
Yndestad A and Aukrust P: Inflammatory cytokines in heart failure:
Mediators and markers. Cardiology. 122:23–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feldman AM, Combes A, Wagner D, Kadakomi
T, Kubota T, Li YY and McTiernan C: The role of tumor necrosis
factor in the pathophysiology of heart failure. J Am Coll Cardiol.
35:537–544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Frangogiannis NG: Chemokines in the
ischemic myocardium: From inflammation to fibrosis. Inflamm Res.
53:585–595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Braunersreuther V, Mach F and Steffens S:
The specific role of chemokines in atherosclerosis. Thromb Haemost.
97:714–721. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ardigo D, Assimes TL, Fortmann SP, Go AS,
Hlatky M, Hytopoulos E, Iribarren C, Tsao PS, Tabibiazar R and
Quertermous T; ADVANCE Investigators, : Circulating chemokines
accurately identify individuals with clinically significant
atherosclerotic heart disease. Physiol Genomics. 31:402–409. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ros C, Gerber M and Kempf C:
Conformational changes in the VP1-unique region of native human
parvovirus B19 lead to exposure of internal sequences that play a
role in virus neutralization and infectivity. J Virol.
80:12017–12024. 2006. View Article : Google Scholar : PubMed/NCBI
|
